Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9120855 Biologic compounds directed against death receptor 5

Patent 9120855 was granted and assigned to Novartis on September, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 8 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 8 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11976126 Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cells
0
Edits on 9 Feb, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 9 Feb, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11891446 Highly potent antibodies binding to death receptor 5
0
Edits on 3 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 3 Dec, 2023
Edits made to:
Article (+482 characters)
Article

Patent abstract

The present invention relates to amino acid sequences that are directed against TRAIL cell surface receptor 2 (herein also “DR5”), as well as to compounds or constructs thereof, and in particular proteins and polypeptides and nucleotides that encode them (referred to herein in their entirety as “NB agents”) and fragments thereof, and pharmaceutically effective variants thereof, and their use in the diagnosis and treatment of DR5 associated diseases and disorders.

Edits on 26 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 26 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=091208550
Edits on 19 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 19 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 09120855 Biologic compounds directed against death receptor 5 US Patent 9120855 Biologic compounds directed against death receptor 5

Infobox
Patent Number
091208550
Patent Number
91208550
Edits on 2 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 2 Apr, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
Novartis
Novartis
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
091208550
Date of Patent
September 1, 2015
0
Patent Application Number
130241740
Date Filed
February 9, 2011
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=091208550
Patent Primary Examiner
‌
Gerald R Ewoldt
0
Edits on 8 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 8 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=09120855
Edits on 3 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 3 Jan, 2022
Edits made to:
Infobox (+8 properties)
‌

 US Patent 09120855 Biologic compounds directed against death receptor 5

Infobox
Is a
Patent
Patent
Current assignee
Novartis
Novartis
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
09120855
Date of patent
September 1, 2015
Patent application number
13024174
Date Filed
February 9, 2011
Patent primary examiner
‌
Gerald R Ewoldt

Find more entities like US Patent 9120855 Biologic compounds directed against death receptor 5

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo